Patents by Inventor Mathieu Michaut

Mathieu Michaut has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclic compounds as receptor modulating therapeutics and methods and uses thereof
    Patent number: 12275732
    Abstract: The present invention relates generally to chemical compounds of formula (I) and methods for their use and preparation. In particular, the invention relates to chemical compounds which are useful in relation to the treatment of diseases, disorders or conditions which would benefit from the modulation of the alpha 7 nicotinic acetylcholine receptor (?7 nAChR), such as anxiety, depression and stress related disorders.
    Type: Grant
    Filed: October 18, 2019
    Date of Patent: April 15, 2025
    Assignee: Bionomics Limited
    Inventors: Lorna Mitchell, Hamish Toop, Belinda Huff, Justin Ripper, Rajinder Singh, Christophe Morice, Jean-Marie Contreras, Patrick Bazzini, Laurent Schaeffer, Mathieu Michaut
  • NOVEL PAR-2 INHIBITORS
    Publication number: 20240066027
    Abstract: The present invention provides novel compounds of formula (I) and pharmaceutical compositions containing these compounds. The compounds of formula (I) can act as PAR-2 inhibitors, which renders these compounds highly advantageous for use in therapy, particularly in the treatment or prevention of pain, an autoimmune disorder, an autoinflammatory disorder, an inflammatory disorder, a central nervous system disorder, spinal cord injury, a metabolic disorder, a gastrointestinal disorder, a cardiovascular disorder, a fibrotic disorder, a respiratory disorder, a skin disorder, an allergic disorder, or cancer.
    Type: Application
    Filed: December 3, 2021
    Publication date: February 29, 2024
    Inventors: Stanislas MAYER, Anne-Laure BLAYO, Mickaël FER, Anaïs BARRÉ, Mathieu MICHAUT, Gaël HOMMET, Stephan SCHANN, Baptiste RUGERI
  • Cyclic compounds as receptor modulating therapeutics and methods and uses thereof
    Publication number: 20210355124
    Abstract: The present invention relates generally to chemical compounds of formula (I) and methods for their use and preparation. In particular, the invention relates to chemical compounds which are useful in relation to the treatment of diseases, disorders or conditions which would benefit from the modulation of the alpha 7 nicotinic acetylcholine receptor (?7 nAChR), such as anxiety, depression and stress related disorders.
    Type: Application
    Filed: October 18, 2019
    Publication date: November 18, 2021
    Inventors: Lorna Mitchell, Hamish Toop, Belinda Huff, Justin Ripper, Rajinder Singh, Christophe Morice, Jean-Marie Contreras, Patrick Bazzini, Laurent Schaeffer, Mathieu Michaut
  • STYRLYQUINOLINES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC USES
    Publication number: 20110224242
    Abstract: The present disclosure concerns new substituted styrylquinolines, the process of their preparation and their therapeutic uses as integrase inhibitors and/or for the treatment and/or prevention of HIV.
    Type: Application
    Filed: July 23, 2009
    Publication date: September 15, 2011
    Applicant: BIOALLIANCE PHARMA
    Inventors: Bruno Giethlen, Mathieu Michaut, Claude Monneret, Emilienne Soma, Laurent Thibault, Camille Georges Wermuth